2014Zhongguo naoxueguanbing zazhiRequires access

Relationship between blood glucose fluctuations and the prognosis of thrombolytic therapy in patients with acute cerebral infarction and type 2 diabetes mellitus

MA Yan-xi

Open publisher page 0 citations

Abstract

Objective To study the effect of blood glucose fluctuations on the prognosis of thrombolytic therapy in patients with acute cerebral infarction. Methods A total of 83 consecutive patients with acute cerebral infarction admitted to the Department of Neurology,General Hospital of Beijing Military Command( the Affiliated 81 st Brain Hospital) from January to November 2013 were enrolled retrospectively. They were divided into cerebral infarction with type 2 diabetes mellitus group( DMCI group,n = 47) and cerebral infarction without type 2 diabetes mellitus group( NDMCI group,n = 36) according to whether they had diabetes mellitus or not and the results of oral glucose tolerance test at day 7 after admission.Continuous glucose monitoring system( CGMS) was used to monitor glucose for 72 hours at day 7after admission. The mean blood glucose,standard deviation of blood glucose level,mean blood glucose fluctuation,and hemorrhagic transformation during the follow-up period,as well as vascular recanalization were observed and compared. At day 90,the modified Rankin scale( mRS) score was used to evaluate the prognosis of the patients. Results( 1) Comparing the dynamic glucose parameters of the patients with acute cerebral infarction in both groups,the mean blood glucose,standard deviation of blood glucose level,mean blood glucose fluctuations at 24 hours in patients of the DMCI group were higher than those of the NDMCI group( 8. 3 ± 2. 6 mmol /L vs. 5. 8 ± 1. 3 mmol /L,2. 1 ± 0. 4 mmol /L vs. 1. 6 ±0. 6 mmol /L,4. 3 ± 0. 8 mmol /L vs. 3. 6 ± 0. 5 mmol /L). There were significant differences( t = 31. 419,15. 537,and 15. 372,respectively; all P 0. 01).( 2) Four patients( 8. 5%) in the DMCI group had hemorrhagic transformation during the follow-up period,17 cases( 36. 2%) had good recanalization,and 15cases( 31. 9%) had good prognosis( the mRS score 2 at day 90); 1 patient( 2. 8%) in the NDMCI group had hemorrhagic transformation,21 patients( 58. 3%) had good recanalization,and 21 cases( 58. 3%)had good prognosis. There was significant difference between the recanalization after thrombolysis and the prognosis in patients of both groups( P 0. 05). Conclusion The great fluctuations of blood glucose in acute cerebral infarction patients with type 2 diabetes mellitus may be an important factor of affecting its prognosis of thrombolytic therapy.

About this research paper

What this paper is about

Objective To study the effect of blood glucose fluctuations on the prognosis of thrombolytic therapy in patients with acute cerebral infarction. Methods A total of 83 consecutive patients with acute cerebral infarction admitted to the Department of Neurology,General Hospital of Beijing Military Command( the Affiliated 81 st Brain Hospital) from January to November 2013 were enrolled retrospectively. They were divided into cerebral infarction with type 2 diabetes mellitus group( DMCI group,n = 47) and cerebral infarction without type 2 diabetes mellitus group( NDMCI group,n = 36) according to whether they had diabetes mellitus or not and the results of oral glucose tolerance test at day 7 after admission.Continuous glucose monitoring system( CGMS) was used to monitor glucose for 72 hours at day 7after admission. The mean blood glucose,standard deviation of blood glucose level,mean blood glucose fluctuation,and hemorrhagic transformation during the follow-up period,as well as vascular recanalization were observed and compared. At day 90,the modified Rankin scale( mRS) score was used to evaluate the prognosis of the patients. Results( 1) Comparing the dynamic glucose parameters of the patients with acute cerebral infarction in both groups,the mean blood glucose,standard deviation of blood glucose level,mean blood glucose fluctuations at 24 hours in patients of the DMCI group were higher than those of the NDMCI group( 8. 3 ± 2. 6 mmol /L vs. 5. 8 ± 1. 3 mmol /L,2. 1 ± 0. 4 mmol /L vs. 1. 6 ±0. 6 mmol /L,4. 3 ± 0. 8 mmol /L vs. 3. 6 ± 0. 5 mmol /L). There were significant differences( t = 31. 419,15. 537,and 15. 372,respectively; all P 0. 01).( 2) Four patients( 8. 5%) in the DMCI group had hemorrhagic transformation during the follow-up period,17 cases( 36. 2%) had good recanalization,and 15cases( 31. 9%) had good prognosis( the mRS score 2 at day 90); 1 patient( 2. 8%) in the NDMCI group had hemorrhagic transformation,21 patients( 58. 3%) had good recanalization,and 21 cases( 58. 3%)had good prognosis. There was significant difference between the recanalization after thrombolysis and the prognosis in patients of both groups( P 0. 05). Conclusion The great fluctuations of blood glucose in acute cerebral infarction patients with type 2 diabetes mellitus may be an important factor of affecting its prognosis of thrombolytic therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the effect of blood glucose fluctuations on the prognosis of thrombolytic therapy in patients with acute cerebral infarction. Methods A total of 83 consecutive patients with acute cerebral infarction admitted to the Department of Neurology,General Hospital of Beijing Military Command( the Affiliated 81 st Brain Hospital) from January to November 2013 were enrolled retrospectively. They were divided into cerebral infarction with type 2 diabetes mellitus group( DMCI group,n = 47) and cerebral infarction without type 2 diabetes mellitus group( NDMCI group,n = 36) according to whether they had diabetes mellitus or not and the results of oral glucose tolerance test at day 7 after admission.Continuous glucose monitoring system( CGMS) was used to monitor glucose for 72 hours at day 7after admission. The mean blood glucose,standard deviation of blood glucose level,mean blood glucose fluctuation,and hemorrhagic transformation during the follow-up period,as well as vascular recanalization were observed and compared. At day 90,the modified Rankin scale( mRS) score was used to evaluate the prognosis of the patients. Results( 1) Comparing the dynamic glucose parameters of the patients with acute cerebral infarction in both groups,the mean blood glucose,standard deviation of blood glucose level,mean blood glucose fluctuations at 24 hours in patients of the DMCI group were higher than those of the NDMCI group( 8. 3 ± 2. 6 mmol /L vs. 5. 8 ± 1. 3 mmol /L,2. 1 ± 0. 4 mmol /L vs. 1. 6 ±0. 6 mmol /L,4. 3 ± 0. 8 mmol /L vs. 3. 6 ± 0. 5 mmol /L). There were significant differences( t = 31. 419,15. 537,and 15. 372,respectively; all P 0. 01).( 2) Four patients( 8. 5%) in the DMCI group had hemorrhagic transformation during the follow-up period,17 cases( 36. 2%) had good recanalization,and 15cases( 31. 9%) had good prognosis( the mRS score 2 at day 90); 1 patient( 2. 8%) in the NDMCI group had hemorrhagic transformation,21 patients( 58. 3%) had good recanalization,and 21 cases( 58. 3%)had good prognosis. There was significant difference between the recanalization after thrombolysis and the prognosis in patients of both groups( P 0. 05). Conclusion The great fluctuations of blood glucose in acute cerebral infarction patients with type 2 diabetes mellitus may be an important factor of affecting its prognosis of thrombolytic therapy.

Key concepts: Medicine, Diabetes mellitus, Internal medicine, Cerebral infarction, Modified Rankin Scale, Infarction, Type 2 Diabetes Mellitus, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Relationship between blood glucose fluctuations and the prognosis of thrombolytic therapy in patients with acute cerebral infarction and type 2 diabetes mellitus — Research Paper | ScholarLens